| Related Knowledge Base Chapters|
| Journal Articles|
|Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example|
Andersson KM, Owens DK, Vardas E, Gray GE, McIntyre JA, Paltiel AD. J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):78-90. Includes commentary from the UCSF Institute for Global Health.
|Enrolling Women into HIV Preventive Vaccine Trials: An Ethical Imperative but a Logistical Challenge|
Mills E, Nixon S, Singh S, Dolma S, Nayyar A, Kapoor S. PLoS Biol. 2006 Feb 21;3(3):e94.
|A sound rationale needed for phase III HIV-1 vaccine trials|
Burton DR, Desrosiers RC, Doms RW, Feinberg MB, Gallo RC, Hahn B, Hoxie JA, Hunter E, Korber B, Landay A, Lederman MM, Lieberman J, McCune JM, Moore JP, Nathanson N, Picker L, Richman D, Rinaldo C, Stevenson M, Watkins DI, Wolinsky SM, Zack JA. Science. 2004 Jan 16;303(5656):316.
See also the responses to this article:
|The need for a global HIV vaccine enterprise|
Klausner RD, Fauci AS, Corey L, Nabel GJ, Gayle H, Berkley S, Haynes BF, Baltimore D, Collins C, Douglas RG, Esparza J, Francis DP, Ganguly NK, Gerberding JL, Johnston MI, Kazatchkine MD, McMichael AJ, Makgoba MW, Pantaleo G, Piot P, Shao Y, Tramont E, Varmus H, Wasserheit JN. Science. 2003 Jun 27;300(5628):2036-9.
|HIV T cell vaccines: the importance of clades|
McMichael A, Mwau M, Hanke T. Vaccine. 2002 May 6;20(15):1918-21.
|HIV vaccine strategies|
Nabel GJ. Vaccine. 2002 May 6;20(15):1945-7.
|New hope for an AIDS vaccine|
Robinson HL. Nat Rev Immunol. 2002 Apr;2(4):239-50.
| Guidelines and Best Practices|
| Policy Reports, Papers, and Briefs|
|AVAC Report 2007 - Resetting the Clock |
AIDS Vaccine Advocacy Coalition, August 2007. [PDF, 3MB] Download individual chapters on the AVAC Web site.
|AIDS Vaccine Blueprint 2006: Actions to Strengthen Global Research and Development|
International AIDS Vaccine Initiative, 2006. [PDF, 2.1MB]
|Advanced Market Commitments: Helping to Accelerate AIDS Vaccine Development|
International AIDS Vaccine Initiative, November 2005. [PDF, 160K]
|Estimating the Global Impact of an AIDS Vaccine|
International AIDS Vaccine Initiative, October 2005. [PDF, 125K]
|Gender in AIDS Vaccine Trials|
International AIDS Vaccine Initiative, November 2004. [PDF, 209K]
| Online Books and Chapters|
| Patient and Community Education|
|AIDS Vaccine Advocacy Coalition|
(AVAC) Advocacy for developing HIV/AIDS vaccines. Site features Vaccine handbook, news articles, official reports, FAQs, and activist manifestos.
|Capital Area Vaccine Effort|
A volunteer panel of individuals from the general public and communities affected by AIDS. Assists and advises vaccine trials in the metropolitan Washington, DC area.
|Global Alliance for Vaccines and Immunization|
Works to expand access to existing vaccines in the developing world and accelerate research on needed vaccines, including HIV vaccines.
|International AIDS Vaccine Initiative|
(IAVI) Works to speed the development and distribution of preventive AIDS vaccines by funding research, mobilizing support through advocacy and education, and encouraging private sector participation in AIDS vaccine development.
|National AIDS Trust (UK)|
UK's leading policy development and advocacy AIDS organisation. Includes a prevention technologies annual update.
|WHO-UNAIDS HIV Vaccine Initiative|
(HVI) Advocacy, information, education, and policy dialogue.
| Vaccine Company Pages|
| Clinical Trial Databases|
AIDSinfo Vaccine Information|
A service of the U.S. Department of Health and Human Services. Includes searchable listings of clinical trials for preventive and therapeutic HIV vaccines, as well as a glossary, HIV vaccine news, and links to related web sites.
|HIV/SIV Vaccine Trials Database|
A project of the Los Alamos National Laboratory.
|International AIDS Vaccine Initiative (IAVI)|
Works to speed the development and distribution of preventive AIDS vaccines by funding research, mobilizing support through advocacy and education, and encouraging private sector participation in AIDS vaccine development.
| Document Collections|